Another study also showed that upregulated miR-155 in patients with CAD may inhibit atherosclerosis progression via targeting mitogen-activated protein kinase kinase kinase 10 (MAP3K10) [29]. The gene discussed is MAP3K10; the disease is atherosclerosis.